Ms. Coglianese brings 8 years of Biotech industry experience and a total of over 25 years’ experience in an Executive Administration role. She has been involved in the support of 10 Biotech startups including 3 through Phase 2 clinical trials, 3 through successful acquisition and others through numerous financing series. She serves as the Executive Administrator of Riva Therapeutics.
Previously, she served as an executive assistant for Lengo Therapeutics (acquired by Blueprint Medicines), Amplyx Pharmaceuticals (acquired by Pfizer) and Mavu Pharma (acquired by AbbVie). She has also provided executive administrator consulting services to various Biotechs including Laguna Pharmaceuticals, Cirius Therapeutics, Abintus Bio, Iolyx Therapeutics, Inipharm and Sudo Biosciences.
Ms. Coglianese received a Bachelor of Science from Siena College.